世界のCAR T細胞療法市場は、2022年に約19億3000万米ドルと評価され、予測期間の2023年から2030年には13.5%以上の健全な成長率で成長すると予測されています。キメラ抗原受容体（CAR）T細胞療法は、新しい形のがん治療で、医療専門家が研究室でT細胞を改変してからがん患者の体内に注入し、がん細胞を検出して排除できるようにするものです。CAR T細胞療法により、免疫系は悪性細胞を認識するように訓練されます。悪性細胞に対する免疫応答は、CAR T細胞治療によって促進されます。CAR T細胞療法の市場は、主に、がん治療に適した治療薬に対する需要の増加、一部の国におけるCAR T細胞療法薬の有利な償還政策、CAR T細胞療法薬に対する消費者の認知度の向上によって牽引されています。さらに、CAR-T細胞療法の最近の商業化および臨床試験活動の急増が、市場拡大にさらなる影響を与えています。
また、白血病やリンパ腫などのがん罹患率の増加が、CAR T細胞療法の需要を直接的に高めています。世界保健機関（WHO）によると、2020年の白血病の患者数は475千人と推定され、2040年には692千人に達すると予測されています。したがって、がんの有病率の増加は、幅広い診断と治療の選択肢に対する需要を促進し、ひいてはCAR T細胞療法市場の成長を加速させることになります。さらに、研究開発への投資の増加や技術の進歩は、予測期間中に様々な有利な機会を提供します。しかし、熟練した専門家の不足とCAR T細胞療法の開発コストの高さが、2023年から2030年の予測期間を通じて市場成長に課題をもたらしています。
CAR T細胞療法の世界市場調査において考慮した主要地域は、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、中東・アフリカです。北アメリカは、規制当局の認可の増加、医療施設の高度化に対する投資の増加、技術開発の進展により、2022年の市場を支配しています。一方、アジア太平洋地域は、予測期間中、最も高いCAGRで成長すると予想されています。癌の有病率の上昇、政府機関による新規治療薬への研究費の増加、新規治療薬に対する意識の高まりと認可の増加が、この地域全体の市場需要を大きく後押ししています。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. CAR T-Cell therapy Market, by Region, 2020-2030 (USD Billion)
1.2.2. CAR T-Cell therapy Market, by Indication, 2020-2030 (USD Billion)
1.2.3. CAR T-Cell therapy Market, by Drug type, 2020-2030 (USD Billion)
1.2.4. CAR T-Cell therapy Market, by End user, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global CAR T-Cell therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global CAR T-Cell therapy Market Dynamics
3.1. CAR T-Cell therapy Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increase in the incidence of cancer such as leukemia and lymphoma
3.1.1.2. Favorable reimbursement policies for CAR T-cell therapy medications
3.1.2. Market Challenges
3.1.2.1. Unavailability of skilled professionals
3.1.2.2. High cost of developing CAR T-cell therapy
3.1.3. Market Opportunities
3.1.3.1. Growing investment in research and development
3.1.3.2. Increasing advancements in technology
Chapter 4. Global CAR T-Cell therapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global CAR T-Cell therapy Market, by Indication
5.1. Market Snapshot
5.2. Global CAR T-Cell therapy Market by Indication, Performance - Potential Analysis
5.3. Global CAR T-Cell therapy Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
5.4. CAR T-Cell therapy Market, Sub Segment Analysis
5.4.1. Lymphoma
5.4.2. Acute Lymphocytic Leukemia
5.4.3. Others
Chapter 6. Global CAR T-Cell therapy Market, by Drug type
6.1. Market Snapshot
6.2. Global CAR T-Cell therapy Market by Drug type, Performance - Potential Analysis
6.3. Global CAR T-Cell therapy Market Estimates & Forecasts by Drug type 2020-2030 (USD Billion)
6.4. CAR T-Cell therapy Market, Sub Segment Analysis
6.4.1. Axicabtagene Ciloleucel
6.4.2. Tisagenlecleucel
6.4.3. Brexucabtagene Autoleucel
6.4.4. Others
Chapter 7. Global CAR T-Cell therapy Market, by End user
7.1. Market Snapshot
7.2. Global CAR T-Cell therapy Market by End user, Performance - Potential Analysis
7.3. Global CAR T-Cell therapy Market Estimates & Forecasts by End user 2020-2030 (USD Billion)
7.4. CAR T-Cell therapy Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Cancer Treatment Centers
Chapter 8. Global CAR T-Cell therapy Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. CAR T-Cell therapy Market, Regional Market Snapshot
8.4. North America CAR T-Cell therapy Market
8.4.1. U.S. CAR T-Cell therapy Market
8.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
8.4.1.2. Drug type breakdown estimates & forecasts, 2020-2030
8.4.1.3. End user breakdown estimates & forecasts, 2020-2030
8.4.2. Canada CAR T-Cell therapy Market
8.5. Europe CAR T-Cell therapy Market Snapshot
8.5.1. U.K. CAR T-Cell therapy Market
8.5.2. Germany CAR T-Cell therapy Market
8.5.3. France CAR T-Cell therapy Market
8.5.4. Spain CAR T-Cell therapy Market
8.5.5. Italy CAR T-Cell therapy Market
8.5.6. Rest of Europe CAR T-Cell therapy Market
8.6. Asia-Pacific CAR T-Cell therapy Market Snapshot
8.6.1. China CAR T-Cell therapy Market
8.6.2. India CAR T-Cell therapy Market
8.6.3. Japan CAR T-Cell therapy Market
8.6.4. Australia CAR T-Cell therapy Market
8.6.5. South Korea CAR T-Cell therapy Market
8.6.6. Rest of Asia Pacific CAR T-Cell therapy Market
8.7. Latin America CAR T-Cell therapy Market Snapshot
8.7.1. Brazil CAR T-Cell therapy Market
8.7.2. Mexico CAR T-Cell therapy Market
8.8. Middle East & Africa CAR T-Cell therapy Market
8.8.1. Saudi Arabia CAR T-Cell therapy Market
8.8.2. South Africa CAR T-Cell therapy Market
8.8.3. Rest of Middle East & Africa CAR T-Cell therapy Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Autolus Therapeutics
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bluebird bio, Inc.
9.3.3. Bristol-Myers Squibb
9.3.4. Caribou Biosciences, Inc.
9.3.5. Cartesian Therapeutics, Inc.
9.3.6. Celgene Corporation
9.3.7. Gilead Sciences, Inc. (Kite Pharma Inc.)
9.3.8. Merck & Co., Inc.
9.3.9. Novartis AG
9.3.10. Pfizer, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global CAR T-Cell therapy Market, report scope
TABLE 2. Global CAR T-Cell therapy Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global CAR T-Cell therapy Market estimates & forecasts by Indication 2020-2030 (USD Billion)
TABLE 4. Global CAR T-Cell therapy Market estimates & forecasts by Drug type 2020-2030 (USD Billion)
TABLE 5. Global CAR T-Cell therapy Market estimates & forecasts by End user 2020-2030 (USD Billion)
TABLE 6. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global CAR T-Cell therapy Market
TABLE 71. List of primary sources, used in the study of global CAR T-Cell therapy Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global CAR T-Cell therapy Market, research methodology
FIG 2. Global CAR T-Cell therapy Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global CAR T-Cell therapy Market, key trends 2022
FIG 5. Global CAR T-Cell therapy Market, growth prospects 2023-2030
FIG 6. Global CAR T-Cell therapy Market, porters 5 force model
FIG 7. Global CAR T-Cell therapy Market, pest analysis
FIG 8. Global CAR T-Cell therapy Market, value chain analysis
FIG 9. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global CAR T-Cell therapy Market, regional snapshot 2020 & 2030
FIG 15. North America CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
FIG 16. Europe CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
FIG 18. Latin America CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
